Riskpilot← Back to searchSign inGet full accessNAPRAPATEN MELHUS AS
ASActiveOrg 911601052Kuhaugen 4, 7224 MelhusTraditional, complementary and alternative medicine activities · NACE 8696Est. 20131 employees
Revenue 2024
NOK 3,3M
0% vs 2023
EBITDA margin
10.6%
-41% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
NOK 268K
-40% vs 2023
| Revenue | NOK 3,3M | +0% |
| EBITDA | NOK 350K | -41% |
| Net profit | NOK 268K | -40% |
| Total assets | NOK 2,4M | +4% |
| Equity | NOK 2M | +6% |
| Employees | 1 | — |
Legal name
NAPRAPATEN MELHUS AS
Org number
911601052
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
21. februar 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Salg av naprapattjenester og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskaper med lignede virksomhet kjøp, salg av aksjer eller på annen måte å gjøre seg interessert i andre foretakender. Selskapet kan også drive utleie av egen fast eller leid eiendom og andre produkter som faller sammen med dette
Address
Kuhaugen 4, 7224 Melhus
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 888 | 3 044 | 3 321 | 3 286 | 3 301 |
| Staff expenses | −286 | −554 | −635 | −745 | −891 |
| EBITDA | 609 | 680 | 627 | 595 | 350 |
| Depreciation & amort. | −2 | −31 | −35 | −36 | −41 |
| EBIT | 606 | 650 | 591 | 559 | 309 |
| Net financials | 1 | −0 | 3 | 16 | 36 |
| Profit before tax | 607 | 649 | 595 | 576 | 346 |
| Tax | 134 | 143 | 131 | 128 | 78 |
| Net profit | 473 | 506 | 464 | 448 | 268 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 349 | 1 749 | 2 035 | 2 314 | 2 415 |
| Equity | 989 | 1 496 | 1 610 | 1 907 | 2 026 |
| Long-term debt | 9 | 8 | 5 | 2 | 0 |
| Short-term debt | 352 | 246 | 421 | 405 | 390 |
| Total debt | 360 | 254 | 425 | 407 | 390 |
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
20202024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
13.2%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20202024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ES Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NAPRAPATEN MELHUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Strickert | Deputy Member | 0 companies |
| Rita Dagslott Strickert | Chairman | 0 companies |